ATE440607T1 - Verfahren zur herstellung von galanthaminhydrobromid - Google Patents

Verfahren zur herstellung von galanthaminhydrobromid

Info

Publication number
ATE440607T1
ATE440607T1 AT05808194T AT05808194T ATE440607T1 AT E440607 T1 ATE440607 T1 AT E440607T1 AT 05808194 T AT05808194 T AT 05808194T AT 05808194 T AT05808194 T AT 05808194T AT E440607 T1 ATE440607 T1 AT E440607T1
Authority
AT
Austria
Prior art keywords
galanthamine
hydrobromide
butyl
galanthamin
producing
Prior art date
Application number
AT05808194T
Other languages
English (en)
Inventor
Bruno Gabetta
Enrico Mercalli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE440607T1 publication Critical patent/ATE440607T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05808194T 2004-12-17 2005-11-23 Verfahren zur herstellung von galanthaminhydrobromid ATE440607T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002413A ITMI20042413A1 (it) 2004-12-17 2004-12-17 Processo per la preparazione di galantamina bromidrato
PCT/EP2005/012521 WO2006063666A1 (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide

Publications (1)

Publication Number Publication Date
ATE440607T1 true ATE440607T1 (de) 2009-09-15

Family

ID=35784718

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05808194T ATE440607T1 (de) 2004-12-17 2005-11-23 Verfahren zur herstellung von galanthaminhydrobromid

Country Status (19)

Country Link
US (1) US8013151B2 (de)
EP (1) EP1861105B1 (de)
JP (1) JP5166878B2 (de)
KR (1) KR101291446B1 (de)
CN (1) CN101080231B (de)
AT (1) ATE440607T1 (de)
AU (1) AU2005315960B2 (de)
CA (1) CA2592288C (de)
DE (1) DE602005016308D1 (de)
DK (1) DK1861105T3 (de)
ES (1) ES2330127T3 (de)
IL (1) IL183933A0 (de)
IT (1) ITMI20042413A1 (de)
NO (1) NO338724B1 (de)
PL (1) PL1861105T3 (de)
PT (1) PT1861105E (de)
RU (1) RU2387656C2 (de)
SI (1) SI1861105T1 (de)
WO (1) WO2006063666A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT507256B1 (de) * 2008-09-04 2010-10-15 Sanochemia Pharmazeutika Ag Verwendung von galanthaminiumbromid zur herstellung von ophthalmischen formulierungen zur glaukombehandlung
US8247405B2 (en) * 2008-12-10 2012-08-21 Conopco, Inc. Skin lightening compositions with acetylcholinesterase inhibitors
CN101787028B (zh) * 2010-01-12 2012-01-04 恩施清江生物工程有限公司 一种从忽地笑中提取加兰他敏的方法
BG110754A (bg) 2010-09-20 2012-03-30 "Ар енд ДИ" ООД Метод и инсталация за екстракция на растителни суровини
BG66818B1 (bg) * 2013-03-07 2019-01-31 Berbee Beheer B. V. Състав на екстракт от hippeastrum papilio за производство на лекарствени средства и хранителни добавки
CN104177368B (zh) * 2014-05-27 2016-06-08 天津梅花医药有限公司 一种氢溴酸加兰他敏化合物、制备方法及其药物组合物
CN103980284B (zh) * 2014-05-30 2016-03-09 天津梅花医药有限公司 一种氢溴酸加兰他敏化合物及其制备方法
CN107462656A (zh) * 2017-07-04 2017-12-12 上海市农业科学院 一种快速检测石蒜科植物中加兰他敏含量的方法
BG67337B1 (bg) 2018-05-23 2021-06-15 Софарма Ад Метод за получаване на пречистен галантамин хидробромид

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942200A (en) 1959-03-02 1963-11-20 Chimiko Pharmazevtitschen Zd A method of obtaining galanthamine hydrobromide
GB938767A (en) 1961-12-13 1963-10-09 Vni Chimico Pharmatsevtichesky The preparation of galanthamine from the amaryllidaceae and its separation from associated alkaloids
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
CN1261434C (zh) * 2003-07-28 2006-06-28 浙江一新制药股份有限公司 从石蒜粗提物中分离高纯度加兰他敏的方法
DE102006033591B4 (de) 2006-07-18 2008-10-16 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. Verfahren zur Stabilisierung der Spinnlösung bei der Herstellung von cellulosischen Verbundformkörpern

Also Published As

Publication number Publication date
JP2008524125A (ja) 2008-07-10
CN101080231B (zh) 2010-11-17
EP1861105A1 (de) 2007-12-05
AU2005315960B2 (en) 2012-01-12
WO2006063666A1 (en) 2006-06-22
SI1861105T1 (sl) 2009-12-31
KR20070095897A (ko) 2007-10-01
AU2005315960A1 (en) 2006-06-22
DK1861105T3 (da) 2009-11-16
JP5166878B2 (ja) 2013-03-21
ITMI20042413A1 (it) 2005-03-17
NO20073053L (no) 2007-06-15
RU2007122353A (ru) 2008-12-20
US8013151B2 (en) 2011-09-06
PT1861105E (pt) 2009-10-22
US20090043092A1 (en) 2009-02-12
CA2592288A1 (en) 2006-06-22
CA2592288C (en) 2014-05-06
KR101291446B1 (ko) 2013-07-30
DE602005016308D1 (de) 2009-10-08
RU2387656C2 (ru) 2010-04-27
HK1113306A1 (en) 2008-10-03
ES2330127T3 (es) 2009-12-04
CN101080231A (zh) 2007-11-28
PL1861105T3 (pl) 2010-02-26
EP1861105B1 (de) 2009-08-26
IL183933A0 (en) 2007-10-31
NO338724B1 (no) 2016-10-10

Similar Documents

Publication Publication Date Title
IL183933A0 (en) Process for the preparation fo galanthamine hydrobromide
ATE410400T1 (de) Verfahren zur herstellung von c13- alkoholgemischen
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
DE602004031907D1 (de) Verfahren zur Herstellung von Nanopartikeln durch grössenspezifische Photoätzung
HUP0301022A2 (hu) Tiotropinium-bromid-monohidrát, eljárás előállítására és alkalmazása gyógyszerkészítmény előállítására
ATE186461T1 (de) Verfahren zur herstellung wasserlöslicher camptothecinanaloge, sowie die verbindungen 10- hydroxy-11-c(1-6)-alkoxycamptothecin
ATE512990T1 (de) Verfahren zur herstellung von gereinigten beta-(1,3)-d-glucanen
ATE423778T1 (de) Verfahren zur herstellung von anthranilsäurederivat-hydrat
ATE518835T1 (de) Kristallform einer chinolinverbindung und verfahren zu deren herstellung
ATE279414T1 (de) Verfahren zur herstellung von reinem triethylendiamin (teda)
ATE386765T1 (de) Verfahren zur herstellung von polycarbonat
DE602005016282D1 (de) Verfahren zur herstellung von camptothecin-derivaten
ATE359287T1 (de) Ein verfahren zur herstellung von clopidogrel
DE502005004950D1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
DE50206754D1 (de) Verfahren zur herstellung von hochreinem triethylendiamin
ATE466010T1 (de) Verfahren zur herstellung von candesartan
ATE406376T1 (de) Verfahren zur herstellung von finasterid form i
ATE457304T1 (de) Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle
DE602005011888D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs, sowie dadurch hergestellter Einlagestoff
ATE513834T1 (de) Verfahren zur herstellung von (s)-(+)- clopidogrelbase und deren salzen
ATE472523T1 (de) Verbessertes verfahren zur herstellung von rivastigmin
DE112004002335D2 (de) Verfahren zur Herstellung von in 2,7-Position substituierten Xanthen-4,5-diolen
DE602004027401D1 (de) Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
DE50113668D1 (de) Verfahren zur herstellung von mintlacton
ATE485387T1 (de) Verfahren zur herstellung enantioreiner beta- aminosäurederivate sowie enantioreine beta- aminosäurederivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1861105

Country of ref document: EP